Virus Like Particles as a Platform for Cancer Vaccine Development

PeerJ - United States
doi 10.7717/peerj.4053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PeerJ

Related search

Virus-Like Particles and Nanoparticles for Vaccine Development Against HCMV

Viruses
VirologyInfectious Diseases
2019English

Vaccine Potential of Nipah Virus-Like Particles

PLoS ONE
Multidisciplinary
2011English

Tetravalent Recombinant Dengue Virus-Like Particles as Potential Vaccine Candidates: Immunological Properties

BMC Microbiology
Microbiology
2014English

Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever Virus

Vector-Borne and Zoonotic Diseases
VirologyInfectious DiseasesMicrobiology
2010English

Structural Analysis of Influenza Vaccine Virus-Like Particles Reveals a Multicomponent Organization

Scientific Reports
Multidisciplinary
2018English

Vesicular Stomatitis Virus as a Vector to Deliver Virus-Like Particles of Human Norovirus: A New Vaccine Candidate Against an Important Noncultivable Virus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Virus Like Particles as Immunogens and Universal Nanocarriers

Polish Journal of Microbiology
Applied MicrobiologyBiotechnologyMicrobiologyMedicine
2015English

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity Against Influenza Virus

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2018English

Letter: Hepatitis a Virus-Like Particles.

BMJ
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy